Emiglitate
CAS:
Ref. 3D-FDA87963
1mg
772.00€
5mg
2,002.00€
10mg
3,203.00€
25mg
6,006.00€
50mg
9,609.00€
Product Information
Name:Emiglitate
Brand:Biosynth
Description:Emiglitate is a postprandial plasma enzyme inhibitor that has been shown to have an inhibitory effect on pancreatic enzymes. It is used as an antidiabetic agent and has been shown in clinical trials to be effective in controlling the blood glucose levels of diabetic patients. Emiglitate inhibits the activity of guanylate cyclase, which is involved in the synthesis of cyclic guanosine monophosphate (cGMP). This drug also inhibits dpp-IV, which is involved in the degradation of glucagon-like peptide-1 (GLP-1), a hormone that stimulates insulin secretion. The inhibition of GLP-1 may contribute to Emiglitate's ability to lower blood sugar levels.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:355.4 g/mol
Formula:C17H25NO7
Purity:Min. 95%
Technical inquiry about: Emiglitate
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.